Sandor Animal Biogenics Profile
Key Indicators
- Authorised Capital ₹ 5.00 Cr
as on 29-12-2024
- Paid Up Capital ₹ 4.01 Cr
as on 29-12-2024
- Company Age 11 Year, 5 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 15.15 Cr
as on 29-12-2024
- Satisfied Charges ₹ 3.75 Cr
as on 29-12-2024
- Revenue 9004.39%
(FY 2021)
- Profit 408.06%
(FY 2021)
- Ebitda 51.59%
(FY 2021)
- Net Worth 89.54%
(FY 2021)
- Total Assets 48.50%
(FY 2021)
About Sandor Animal Biogenics
The Company is engaged in the Agriculture Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 5.00 Cr and a paid-up capital of Rs 4.01 Cr.
The company currently has active open charges totaling ₹15.15 Cr. The company has closed loans amounting to ₹3.75 Cr, as per Ministry of Corporate Affairs (MCA) records.
Gunjan Sindhi and Nirbhay Sindhi serve as directors at the Company.
- CIN/LLPIN
U01119TG2013PTC089274
- Company No.
089274
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
31 Jul 2013
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Sandor Animal Biogenics?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Gunjan Sindhi  | Director | 31-Jul-2013 | Current |
| Nirbhay Sindhi | Director | 10-Jul-2023 | Current |
Financial Performance of Sandor Animal Biogenics.
Sandor Animal Biogenics Private Limited, for the financial year ended 2021, experienced significant growth in revenue, with a 9004.39% increase. The company also saw a substantial improvement in profitability, with a 408.06% increase in profit. The company's net worth Soared by an impressive increase of 89.54%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sandor Animal Biogenics?
In 2021, Sandor Animal Biogenics had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Sandor Speciality Diagnostics Private LimitedActive 6 years 7 monthsGunjan Sindhi is a mutual person
Innovative Development Educational Technologies Private LimitedActive 11 months 1 dayGunjan Sindhi is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
State Bank Of India Creation Date: 23 Jan 2023 | ₹3.15 Cr | Open |
State Bank Of India Creation Date: 01 Sep 2020 | ₹12.00 Cr | Open |
State Bank Of India Creation Date: 30 Mar 2017 | ₹3.75 Cr | Satisfied |
How Many Employees Work at Sandor Animal Biogenics?
Unlock and access historical data on people associated with Sandor Animal Biogenics, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sandor Animal Biogenics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sandor Animal Biogenics's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
